X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (343) 343
Publication (73) 73
Book Chapter (9) 9
Book Review (4) 4
Paper (4) 4
Conference Proceeding (3) 3
Book / eBook (1) 1
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (175) 175
hematology (164) 164
transplantation (150) 150
index medicus (122) 122
female (114) 114
adult (113) 113
male (110) 110
middle aged (99) 99
hematology, oncology and palliative medicine (84) 84
immunology (81) 81
article (73) 73
bone-marrow-transplantation (73) 73
chronic disease (70) 70
hematopoietic stem cell transplantation - adverse effects (60) 60
stem-cell transplantation (56) 56
aged (54) 54
hematopoietic stem cell transplantation (54) 54
transplantation, homologous (53) 53
consensus development project (50) 50
adolescent (47) 47
clinical-trials (42) 42
hematopoietic stem cells (42) 42
working group-report (42) 42
cancer (41) 41
graft vs host disease - diagnosis (37) 37
young adult (37) 37
chronic graft-versus-host disease (36) 36
treatment outcome (35) 35
stem cells (34) 34
versus-host-disease (34) 34
research (33) 33
child (32) 32
diagnosis (31) 31
graft vs host disease - pathology (30) 30
hematopoietic stem cell transplantation - methods (28) 28
united states (28) 28
abridged index medicus (27) 27
bone marrow (27) 27
chronic gvhd (26) 26
criteria (26) 26
graft vs host disease - etiology (25) 25
graft vs host disease - immunology (25) 25
graft vs host disease - mortality (25) 25
graft vs host disease - therapy (25) 25
medical colleges (25) 25
oncology, experimental (25) 25
care and treatment (24) 24
oncology (24) 24
therapy (24) 24
risk factors (23) 23
severity of illness index (23) 23
child, preschool (22) 22
health aspects (22) 22
hemic and lymphatic diseases (22) 22
prognosis (22) 22
survival analysis (22) 22
clinical trials (21) 21
retrospective studies (20) 20
leukemia (19) 19
analysis (18) 18
graft versus host reaction (18) 18
national institutes of health (18) 18
blood (17) 17
immunosuppressive agents - therapeutic use (17) 17
prospective studies (17) 17
survival (17) 17
allogeneic hematopoietic cell transplantation (16) 16
clinical trials as topic (16) 16
disease-free survival (16) 16
hematologic neoplasms - therapy (16) 16
immune system diseases (16) 16
mortality (15) 15
chemotherapy (14) 14
cohort studies (14) 14
consensus (14) 14
follow-up studies (14) 14
graft vs host disease - prevention & control (14) 14
gvhd (14) 14
quality of life (14) 14
stem cell transplantation (14) 14
surgical procedures, operative (14) 14
survival rate (14) 14
acute myeloid-leukemia (13) 13
risk-factors (13) 13
bone marrow transplantation (12) 12
medical research (12) 12
political corruption (12) 12
transplantation conditioning (12) 12
transplantation, autologous (12) 12
allogeneic (11) 11
antineoplastic agents - therapeutic use (11) 11
bone-marrow (11) 11
graft vs host disease - complications (11) 11
graft vs host disease - drug therapy (11) 11
graft vs host disease - physiopathology (11) 11
immunotherapy (11) 11
medicine, experimental (11) 11
recurrence (11) 11
systemic-lupus-erythematosus (11) 11
cross-sectional studies (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, ISBN 9780521884235, xiii, 422
Chronic graft versus host disease (GVHD) is the most common complication of allogenic bone marrow transplantation. Because of the protracted clinical course of... 
Graft versus host disease | Immunosuppression | Immunosuppressive Agents | Chronic Disease | therapy | Graft vs Host Disease
Book
JOURNAL OF HEMATOLOGY & ONCOLOGY, ISSN 1756-8722, 04/2017, Volume 10, Issue 1, pp. 94 - 10
The field of immunotherapy in cancer treatments has been accelerating over recent years and has entered the forefront as a leading area of ongoing research and... 
Hematologic malignancies | Stem cell transplantation | BRENTUXIMAB VEDOTIN | OPEN-LABEL | MODIFIED T-CELLS | ACUTE MYELOID-LEUKEMIA | HODGKIN-LYMPHOMA | B-CELL | ONCOLOGY | Immunotherapy | CHIMERIC-ANTIGEN-RECEPTOR | ACUTE LYMPHOBLASTIC-LEUKEMIA | ENGAGER BITE ANTIBODY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Hematologic Neoplasms - therapy | Humans | Neoplasm Proteins - immunology | Antibodies, Monoclonal - therapeutic use | Neoplasm Proteins - antagonists & inhibitors | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Recombinant Fusion Proteins | T-Lymphocytes - transplantation | Allografts | Immunoconjugates - therapeutic use | Receptors, Antigen, T-Cell - immunology | Immunotherapy, Adoptive | Hematopoietic Stem Cell Transplantation | Clinical Trials as Topic | CTLA-4 Antigen - immunology | B7-H1 Antigen - immunology | Forecasting | Antibodies, Bispecific - therapeutic use | B7-H1 Antigen - antagonists & inhibitors | Antineoplastic Agents, Immunological - therapeutic use | CD3 Complex - immunology | Receptors, Antigen, T-Cell - genetics | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Antigens | Immunoglobulins | Transplants & implants | Cytokines | Research & development--R&D | Leukemia | Cytotoxicity | T cell receptors | Cancer therapies | Chemotherapy | Lymphocytes | Stem cells | Lymphomas | Immune system | Cancer
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 22, pp. 2267 - 2280
PurposeTherapies with novel mechanisms of action are needed for multiple myeloma (MM). T cells can be genetically modified to express chimeric antigen... 
SURVIVAL | THERAPY | ONCOLOGY | CD19 | PROGRESS | LYMPHOMA | MALIGNANCIES | BCMA | SENESCENCE | TRANSPLANTATION | LYMPHOCYTES | ORIGINAL REPORTS
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, p. S261
Journal Article
Journal Article
Blood, ISSN 0006-4971, 06/2018, Volume 131, Issue 24, pp. 2617 - 2620
Immune therapies are fast becoming paradigm-changing treatment options for patients with hematologic cancers. The field has grown exponentially as it expands... 
REMISSIONS | CD19 | CHIMERIC ANTIGEN RECEPTOR | MODIFIED T-CELLS | HODGKIN-LYMPHOMA | LEUKEMIA | HEMATOLOGY | ADOPTIVE IMMUNOTHERAPY | MYELOMA
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 3, pp. 389 - 401.e1
Journal Article